Dysregulated heme oxygenase-ferritin system in pterygium pathogenesis

Cornea

Volumn 32, Issue 9, 2013, Pages 1276-1282

  Fox, Timothy ^a   Gotlinger, Katherine H ^a   Dunn, Michael W ^a   Lee, Olivia L ^b   Milman, Tatyana ^c   Zaidman, Gerald ^a   Schwartzman, Michal L ^a   Bellner, Lars ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c NEW YORK EYE AND EAR INFIRMARY   (United States)

Author keywords

eicosanoids; ferritin; heme oxygenase; inflammation; pterygium

Indexed keywords

12 HYDROXYICOSATETRAENOIC ACID; CYTOCHROME P450 4B1; FERRITIN; HEME OXYGENASE; LIPOXYGENASE; MESSENGER RNA; PROSTAGLANDIN E2; THROMBOXANE B2;

ADULT; ARTICLE; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; EXCISION; FEMALE; HUMAN; HUMAN TISSUE; LIPIDOMICS; LIQUID CHROMATOGRAPHY; MALE; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PTERYGIUM; TANDEM MASS SPECTROMETRY;

12-HYDROXY-5,8,10,14-EICOSATETRAENOIC ACID; ADULT; ARYL HYDROCARBON HYDROXYLASES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DINOPROSTONE; FEMALE; FERRITINS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HEME OXYGENASE (DECYCLIZING); HEME OXYGENASE-1; HUMANS; HYDROXYEICOSATETRAENOIC ACIDS; ISOENZYMES; MALE; MIDDLE AGED; PTERYGIUM; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; TEARS; THROMBOXANE B2;

EID: 84883263988     PISSN: 02773740     EISSN: 15364798     Source Type: Journal    
DOI: 10.1097/ICO.0b013e3182936915     Document Type: Article

References (49)

1. Kheirkhah A, Casas V, Sheha H, et al. Role of conjunctival inflammation in surgical outcome after amniotic membrane transplantation with or without fibrin glue for pterygium. Cornea. 2008;27:56-63.
2. Hirst LW. The treatment of pterygium. Surv Ophthalmol. 2003;48:145-180. (Pubitemid 36398572)
3. Hirst LW. Recurrent pterygium surgery using pterygium extended removal followed by extended conjunctival transplant: recurrence rate and cosmesis. Ophthalmology. 2009;116:1278-1286.
4. Abraham NG, Kappas A. Pharmacological and clinical aspects of heme oxygenase. Pharmacol Rev. 2008;60:79-127. (Pubitemid 351439218)
5. Stohs SJ, Bagchi D. Oxidative mechanisms in the toxicity of metal ions. Free Radic Biol Med. 1995;18:321-336.
6. Cai CX, Birk DE, Linsenmayer TF. Ferritin is a developmentally regulated nuclear protein of avian corneal epithelial cells. J Biol Chem. 1997; 272:12831-12839. (Pubitemid 27203385)
7. Cai CX, Birk DE, Linsenmayer TF. Nuclear ferritin protects DNA from UV damage in corneal epithelial cells. Mol Biol Cell. 1998;9:1037-1051. (Pubitemid 28457298)
8. Zhong JL, Raval C, Edwards GP, et al. A role for Bach1 and HO-2 in suppression of basal and UVA-induced HO-1 expression in human keratinocytes. Free Radic Biol Med. 2010;48:196-206.
9. McCoubrey WK Jr, Huang TJ, Maines MD. Heme oxygenase-2 is a hemoprotein and binds heme through heme regulatory motifs that are not involved in heme catalysis. J Biol Chem. 1997;272:12568-12574. (Pubitemid 27203350)
10. Abraham NG, da Silva JL, Lavrovsky Y, et al. Adenovirus-mediated heme oxygenase-1 gene transfer into rabbit ocular tissues. Invest Ophthalmol Vis Sci. 1995;36:2202-2210.
11. Bellner L, Martinelli L, Halilovic A, et al. Heme oxygenase-2 deletion causes endothelial cell activation marked by oxidative stress, inflammation, and angiogenesis. J Pharmacol Exp Ther. 2009;331:925-932.
12. Bellner L, Patil KA, Castellano K, et al. Targeted suppression of HO-2 gene expression impairs the innate anti-inflammatory and repair responses of the cornea to injury. Mol Vis. 2011;17:1144-1152.
13. Bellner L, Vitto M, Patil KA, et al. Exacerbated corneal inflammation and neovascularization in the HO-2 null mice is ameliorated by biliverdin. Exp Eye Res. 2008;87:268-278.
14. Bellner L, Wolstein J, Patil KA, et al. Biliverdin Rescues the HO-2 Null Mouse Phenotype of Unresolved Chronic Inflammation Following Corneal Epithelial Injury. Invest Ophthalmol Vis Sci. 2011;52:3246-3253.
15. Biteman B, Hassan IR, Walker E, et al. Interdependence of lipoxin A4 and heme-oxygenase in counter-regulating inflammation during corneal wound healing. FASEB J. 2007;21:2257-2266. (Pubitemid 47026460)
16. Halilovic A, Patil KA, Bellner L, et al. Knockdown of heme oxygenase-2 impairs corneal epithelial cell wound healing. J Cell Physiol. 2011;226: 1732-1740.
17. Patil K, Bellner L, Cullaro G, et al. Heme oxygenase-1 induction attenuates corneal inflammation and accelerates wound healing after epithelial injury. Invest Ophthalmol Vis Sci. 2008;49:3379-3386.
18. Seta F, Bellner L, Rezzani R, et al. Heme oxygenase-2 is a critical determinant for execution of an acute inflammatory and reparative response. Am J Pathol. 2006;169:1612-1623. (Pubitemid 351181993)
19. Abraham NG, Lin JH, Dunn MW, et al. Presence of heme oxygenase and NADPH cytochrome P-450 (c) reductase in human corneal epithelium. Invest Ophthalmol Vis Sci. 1987;28:1464-1472. (Pubitemid 17147775)
20. Sacerdoti D, Bolognesi M, Di Pascoli M, et al. Rat mesenteric arterial dilator response to 11,12-epoxyeicosatrienoic acid is mediated by activating heme oxygenase. Am J Physiol Heart Circ Physiol. 2006;291: H1999-H2002. (Pubitemid 44497709)
21. Sacerdoti D, Colombrita C, Di Pascoli M, et al. 11,12-epoxyeicosatrienoic acid stimulates heme-oxygenase-1 in endothelial cells. Prostaglandins Other Lipid Mediat. 2007;82:155-161. (Pubitemid 44880175)
22. Haider A, Olszanecki R, Gryglewski R, et al. Regulation of cyclooxygenase by the heme-heme oxygenase system in microvessel endothelial cells. J Pharmacol Exp Ther. 2002;300:188-194. (Pubitemid 34028526)
23. Hardy P, Beauchamp M, Sennlaub F, et al. Inflammatory lipid mediators in ischemic retinopathy. Pharmacol Rep. 2005;57(suppl):169-190.
24. Gubitosi-Klug RA, Talahalli R, Du Y, et al. 5-Lipoxygenase, but not 12/15-lipoxygenase, contributes to degeneration of retinal capillaries in a mouse model of diabetic retinopathy. Diabetes. 2008;57:1387-1393.
25. Laniado Schwartzman M, Green K, Edelhauser HF, et al. In Cytochrome P450 and Arachidonic Acid Metabolism in the Corneal Epithelium: Role in Inflammation. New York, NY: Plenum Press; 1997;3-20.
26. Gronert K. Lipoxins in the eye and their role in wound healing. Prostaglandins Leukot Essent Fatty Acids. 2005;73:221-229. (Pubitemid 41253479)
27. Node K, Huo Y, Ruan X, et al. Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids. Science. 1999;285: 1276-1279. (Pubitemid 29398616)
28. Eisenstein RS, Garcia-Mayol D, Pettingell W, et al. Regulation of ferritin and heme oxygenase synthesis in rat fibroblasts by different forms of iron. Proc Natl Acad Sci USA. 1991;88:688-692. (Pubitemid 21916088)
29. Lanceta L, Li C, Choi AM, et al. Haem oxygenase-1 overexpression alters intracellular iron distribution. Biochem J. 2013;449:189-194.
30. Mezentsev A, Mastyugin V, Seta F, et al. Transfection of cytochrome P4504B1 into the cornea increases angiogenic activity of the limbal vessels. J Pharmacol Exp Ther. 2005;315:42-50. (Pubitemid 41380496)
31. Kuwano T, Nakao S, Yamamoto H, et al. Cyclooxygenase 2 is a key enzyme for inflammatory cytokine-induced angiogenesis. FAEBS J. 2004;18:300-310. (Pubitemid 38186249)
32. Laniado-Schwartzman M, Abraham NG, Conners M, et al. Heme oxygenase induction with attenuation of experimentally induced corneal inflammation. Biochem Pharmacol. 1997;53:1069-1075. (Pubitemid 27224252)
33. Seta F, Patil K, Bellner L, et al. Inhibition of VEGF expression and corneal neovascularization by siRNA targeting cytochrome P450 4B1. Prostaglandins Other Lipid Mediat. 2007;84:116-127. (Pubitemid 350030578)
34. Chiang CC, Cheng YW, Lin CL, et al. Cyclooxygenase 2 expression in pterygium. Mol Vis. 2007;13:635-638.
35. Park CY, Choi JS, Lee SJ, et al. Cyclooxygenase-2-expressing macrophages in human pterygium co-express vascular endothelial growth factor. Mol Vis. 2011;17:3468-3480.
36. Synowiec E, Szaflik J, Chmielewska M, et al. An association between polymorphism of the heme oxygenase-1 and-2 genes and age-related macular degeneration. Mol Biol Rep. 2012;39:2081-2087.
37. Di Girolamo N, Kumar RK, Coroneo MT, et al. UVB-mediated induction of interleukin-6 and-8 in pterygia and cultured human pterygium epithelial cells. Invest Ophthalmol Vis Sci. 2002;43:3430-3437. (Pubitemid 35334350)
38. Kria L, Ohira A, Amemiya T. Immunohistochemical localization of basic fibroblast growth factor, platelet derived growth factor, transforming growth factor-beta and tumor necrosis factor-alpha in the pterygium. Acta Histochem. 1996;98:195-201. (Pubitemid 26161915)
39. Perra MT, Maxia C, Corbu A, et al. Oxidative stress in pterygium: relationship between p53 and 8-hydroxydeoxyguanosine. Mol Vis. 2006;12:1136-1142. (Pubitemid 44480566)
40. Tsai YY, Cheng YW, Lee H, et al. Oxidative DNA damage in pterygium. Mol Vis. 2005;11:71-75. (Pubitemid 41358306)
41. Willis D, Moore AR, Frederick R, et al. Heme oxygenase: a novel target for the modulation of the inflammatory response. Nat Med. 1996;2:87-90. (Pubitemid 26029572)
42. Willoughby DA, Moore AR, Colville-Nash PR, et al. Resolution of inflammation. Int J Immunopharmacol. 2000;22:1131-1135. (Pubitemid 32012972)
43. Akasaka E, Takekoshi S, Horikoshi Y, et al. Protein oxidative damage and heme oxygenase in sunlight-exposed human skin: roles of MAPK responses to oxidative stress. Tokai J Exp Clin Med. 2010;35:152-164.
44. Ding Y, Zhang YZ, Furuyama K, et al. Down-regulation of heme oxygenase-2 is associated with the increased expression of heme oxygenase-1 in human cell lines. FEBS J. 2006;273:5333-5346. (Pubitemid 44772391)
45. Pourzand C, Watkin RD, Brown JE, et al. Ultraviolet A radiation induces immediate release of iron in human primary skin fibroblasts: the role of ferritin. Proc Natl Acad Sci USA. 1999;96:6751-6756. (Pubitemid 29274955)
46. Millholland JM, Fitch JM, Cai CX, et al. Ferritoid, a tissue-specific nuclear transport protein for ferritin in corneal epithelial cells. J Biol Chem. 2003;278:23963-23970. (Pubitemid 36830225)
47. Balci M, Sahin S, Mutlu FM, et al. Investigation of oxidative stress in pterygium tissue. Mol Vis. 2011;17:443-447.
48. Conners MS, Stoltz RA, Davis KL, et al. A closed eye contact lens model of corneal inflammation. Part 2: Inhibition of cytochrome P450 arachidonic acid metabolism alleviates inflammatory sequelae. Invest Ophthalmol Vis Sci. 1995;36:841-850.
49. Serhan CN, Savill J. Resolution of inflammation: the beginning programs the end. Nat Immunol. 2005;6:1191-1197. (Pubitemid 43045627)